Paracetamol Prices

Paracetamol Prices June 2024

The paracetamol prices in the United States for Q2 2024 reached 3840 USD/MT in June. The market has witnessed some substantial price shifts in the region. A negative trend in prices has been the defining feature of the quarter, with plentiful stockpiles and declining consumption driving down prices majorly. The price drop has been made worse by seasonal considerations, which usually lead to lower adoption rate throughout this duration.

The price trend for paracetamol in China for Q2 2024 settled at 3560 USD/MT in June. The most notable pricing changes in the region, took place in an atmosphere that was mostly stable. Increasing product adoption with the reopening of the market after Lunar New Year, along with rising manufacturing procedures, caused prices to initially soar. During the latter portion of Q2, careful stock management by sellers and seasonality caused prices to balance.

In Germany, the paracetamol prices for Q2 2024 reached 3745 USD/MT in June. Due to an oversupply issue, the European market saw a significant price decline in Q2 2024. Large purchases made in advance of increased demand led to excess stockpiles around the area. As a result of increased inflationary pressures, this overstock was worsened by a decline in customer satisfaction and a decrease in purchase activity. Prices were also under pressure to decline as a result of lower freight costs and a drop in disruptions caused globally.

Paracetamol Prices December 2023

The paracetamol prices in the United States for Q4 2023 reached 4990 USD/MT in December. The prices climbed due to consistent demand and international shipping disruptions. Trade tensions and increased freight costs further impacted the market, while improved economic indicators like reduced unemployment and higher consumer confidence partially balanced these pressures, helping to maintain stability despite inflation and global economic uncertainties.

The price trend for paracetamol in China for Q4 2023, reached 4770 USD/MT in December. The prices fluctuated, with initially declining due to adequate supply and later rebounding with stronger demand from end-users and economic stability. Factors such as changes in production costs and currency depreciation also contributed to this volatility, as suppliers adjusted strategies to ensure profitability amid shifting market conditions.

The price trend for paracetamol in Germany for Q4 2023, reached 5054 USD/MT in December. A significant price increase was observed, driven by higher consumer demand, seasonal needs, and limited inventory. Moreover, rising costs of raw materials and global shipping disruptions added further strain. Market participants adjusted prices to navigate the complexities of increased demand and supply chain challenges, aiming to maximize profits amidst the fluctuating conditions.

Regional Coverage

The report provides a detailed analysis of the paracetamol market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the paracetamol price trend.

Global Paracetamol Price

The report offers a holistic view of the global paracetamol pricing trends in the form of paracetamol price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights the current price but also provides insights into paracetamol historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into paracetamol price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed paracetamol demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Paracetamol Price

Q2 2024:

A situation of oversupply caused a sharp decline in pricing in the European paracetamol market in Q2 2024. Large purchases made in advance of increased demand led to excess stockpiles around the area. As a result of increased inflationary pressures, this overstock was made worse by a decline in consumer confidence and a decrease in purchase activity. Prices were also under pressure to decline as a result of lower freight costs and a drop in geopolitical tensions.

Q4 2023:

In Q4 2023, the paracetamol market in Europe faced several challenges that drove prices up across the region. Germany, a key market, experienced sharp price increases due to elevated demand and limited supply. Seasonal factors, such as a rise in cold-related illnesses, boosted the need for over-the-counter medications, amplifying consumer demand. Additionally, rising global freight costs and higher prices for essential raw materials like para-aminophenol added further upward pressure. Supply chain disruptions from geopolitical tensions, particularly in critical trade routes, exacerbated the situation, leading market participants to increase prices amid scarcity and inflated costs. The market saw a cautious approach from businesses aiming to capitalize on limited inventory and manage increased expenses effectively.

This analysis can be extended to include detailed paracetamol price information for a comprehensive list of countries.

North America Paracetamol Price

Q2 2024:

The North American paracetamol market has seen a steady price reduction in Q2 2024 due to a number of variables that have made the pricing environment difficult. The price of paracetamol has decreased as a result of lower freight expenses brought on by the defusing of geopolitical tensions. Meanwhile, market sentiment has been muted by large stocks from previous bulk purchases. Demand has been further limited by decreased consumer confidence and purchase activity as well as continuing inflationary pressures.

Q4 2023:

In Q4 2023, North America experienced an upward trend in paracetamol prices due to steady demand and disruptions in global trade. Geopolitical tensions caused increased freight costs, particularly impacting routes through the Suez Canal and Red Sea, which added to supply chain expenses. As a key importer, the U.S. market played a significant role in influencing these dynamics. The price movements in the U.S. paralleled those in exporting nations, creating a global ripple effect. Despite logistical challenges and geopolitical issues, there was a positive shift in market sentiment in November, driven by increased business investments and lower unemployment rates, which helped stabilize prices despite inflation concerns and economic uncertainty.

Specific paracetamol historical data within the United States and Canada can also be provided.

Middle East and Africa Paracetamol Price

The report explores the paracetamol pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on paracetamol prices for countries can also be provided.

Asia Pacific Paracetamol Price

Q2 2024:

With a stable supply and demand dynamics, the market of this region showed remarkable stability in Q2 2024. Despite pressure from changing energy prices and the cost of raw materials, the equilibrium was maintained. The market saw stable prices, since there were no significant plant shutdowns or disruptions. This stability was also facilitated by consistent stock levels and conservative downstream industry procurement methods.

Q4 2023:

During Q4 2023, the Asia-Pacific region saw fluctuating paracetamol prices, beginning with a dip due to sufficient supply and inventory levels. This stability was short-lived as increased demand from various sectors prompted a rebound in prices. The market conditions in China improved, backed by economic resilience and supportive policies, despite earlier reductions in raw material costs. Suppliers adjusted their pricing to maintain profitability as the production expenses, influenced by raw material costs, stabilized. Additionally, shifts in currency values further contributed to price increases, with the depreciation of local currencies against the dollar adding pressure on domestic markets. The demand for paracetamol rose steadily, driven by seasonal factors and higher end-user requirements.

This paracetamol price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Paracetamol Price

The analysis of paracetamol prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Paracetamol Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Paracetamol Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2024 Edition,” offers an in-depth analysis of paracetamol pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of paracetamol at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of paracetamol price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing paracetamol price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Paracetamol Market Analysis

The global paracetamol market size reached US$ 746.1 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 1085.1 Million, at a projected CAGR of 4.30% during 2023-2032.

• The primary factor driving the market growth is the persistent need for pharmaceuticals such as paracetamol due to the rising global prevalence of fever and pain-related illnesses.
• Besides this, the expanding geriatric population, prone to chronic conditions and pain-related illnesses is boosting the need for painkillers like paracetamol. Based on the United Nations 2022 Revision of World Population Prospects, the proportion of the global population aged 65 or older will increase from 10% in 2022 to 16% in 2050. By 2050, the number of people 65 and older is predicted to nearly equal the number of children under 12 and surpass the whole population of children under the age of 5 worldwide.
• Furthermore, the market is growing as a result of rising epidemic and pandemic outbreaks, such as the COVID-19 pandemic, which are driving up demand for drugs like paracetamol that lower fever. For instance, in the wake of COVID-19 crisis, the French government partnered with pharmaceutical companies Seqens, Upsa, and Sanofi to construct local manufacturing of paracetamol in the country.
• Along with this, the flourishing expansion of the pharmaceutical industry leading to greater availability and accessibility of paracetamol products is acting as another significant growth-inducing factor.
• Additionally, supportive government programs aimed at alleviating healthcare access have widened the availability and affordability of paracetamol, propelling the market forward.
• Furthermore, continuous innovation and development, as well as extensive investments in research and development (R&D) projects to release new formulations, combinations, and dosage forms of paracetamol, is creating a positive outlook for market.
• Concurrently, favorable changes in regulatory frameworks, such as approvals for new indications or formulations combined with the availability of generic versions of paracetamol at lower costs are presenting lucrative opportunities for market growth. For example, the U.S. Food and Drug Administration (FDA) approved GlaxoSmithKline’s advil dual action with acetaminophen In March 2020 as an over-the-counter (OTC) product for pain relief.
• As per the American Migraine Foundation, an estimated 3–5% of the U.S. population suffers from chronic migraine, with 15 or more headaches per month. This expanding patient pool, driven by rising urbanization and associated lifestyle changes, such as sedentary lifestyles and stress is contributing to increasing demand and sales of paracetamol.

Paracetamol News

The report covers the latest developments, updates, and trends impacting the global paracetamol market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in paracetamol production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the paracetamol price trend.

Latest developments in the paracetamol industry:

• In April 2022, IOL Chemicals & Pharmaceuticals Ltd. announced that it has begun its commercial production of paracetamol with installed capacity of 1,800 MTPA along with backward integration of para–amino phenol (PAP). Aside from this, the company also announced its intention to quadruple paracetamol outturn to 3,600 MTPA by Q3 2023, investing Rs 25 crore internally.
• In March of 2022, Paraveganio launched the world’s first paracetamol to bear The Vegan Society's Vegan Trademark. This certified vegan drug contains 500mg of paracetamol, using magnesium stearate sourced entirely from vegetables.

Product Description

Paracetamol commonly known as acetaminophen in some regions, is one of the most extensively employed medicine, that is popular for its analgesic, i.e., pain-relieving and antipyretic or fever-reducing qualities. It belongs to the class of drugs called analgesics and is generally used to treat mild to moderate pain as well as fever. Paracetamol works by blocking the generation of certain brain chemicals that transmit pain signals and control body temperature.

This medication is marketed in an array of forms, including tablets, capsules, syrups, and effervescent powders, making it easy to use orally. It is frequently used to treat headaches, toothaches, muscular pains, arthritis, and fever caused by colds and flu.

Paracetamol is regarded as a relatively safe medication when taken in accordance with approved dosages. However, exceeding the recommended amount can harm liver, making it crucial to follow prescribed guidelines and parameters.

Paracetamol is widely available for self-medication since it is frequently found as an active component in several OTC cold and flu drugs. It is a staple in cabinets throughout the world, providing millions of people relief from pain and fever, everyday.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of paracetamol pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting paracetamol price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The paracetamol price charts ensure our clients remain at the forefront of the industry.